Pradžia › Meningioma › Florida
Meningioma klinikiniai tyrimai Florida
7 tyrimai dėl Meningioma ieško dalyvių vietose Florida.
Miestai Florida
Oficialus tyrimo tekstas (anglų kalba)
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- Boca Raton Regional Hospital, Boca Raton
- UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
- Holy Cross Hospital, Fort Lauderdale
- ir dar 6
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT02523014Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment
- Baptist MD Anderson Cancer Center, Jacksonville
- University of Miami, Miami
- Baptist Health Medical Group Oncology, Miami
- ir dar 1
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT06955169A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
- Mayo Clinic_Jacksonville, Jacksonville
- Baptist Health Miami Cancer Institute, Miami
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-08 · NCT07428616Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
- University of Miami, Miami
Renkami dalyviai2 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-09-02 · NCT04374305Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
- BayCare Health, Clearwater
- Ascension St. Vincent's, Jacksonville
- Miami Cancer Institute, Baptist Health South Florida, Miami
- ir dar 4
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-07-22 · NCT04427384Cabozantinib for Patients With Recurrent or Progressive Meningioma
- Miami Cancer Institute at Baptist Health, Inc., Miami
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-14 · NCT05425004Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
- Mayo Clinic, Jacksonville
- Biogenix Molecular, Miami
Renkami dalyviai1/2 fazė
Amžius nuo 18 iki 90 · Visoms lytims · Atnaujinta 2026-05-14 · NCT05636618Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.